Literature DB >> 3486045

Endotoxin-mediated necrosis and regression of established tumours in the mouse. A correlative study of quantitative changes in blood flow and ultrastructural morphology.

G G MacPherson, R J North.   

Abstract

The fractional distribution of cardia output was measured in tumour-bearing mice treated with 50 micrograms intravenous endotoxin, and correlated with ultrastructural changes in tumour morphology. The proportion of the cardiac output going to the tumour decreased to less than 50% of its original value by 2 h and to 10%-30% by 6 h after giving endotoxin. Because endotoxin decreases absolute cardiac output, the actual perfusion of the tumour will be considerably less than these figures suggest. The decrease in perfusion correlated closely with changes in vascular morphology. Venous congestion on the tumour edge started within 1 h of giving endotoxin and by 3 h, endothelial damage and platelet aggregates were visible. At this time, all cells, tumour, connective tissue and infiltrate in the tumour centre were dead or damaged. By 24-48 h a conspicuous infiltrate of neutrophils and macrophages was present on the edge of the tumour and many of these cells were closely related to tumour cells. We suggest that the haemorrhagic necrosis may be caused by vascular obstruction leading to hypoxia and that the subsequent regression is mediated by activated macrophages and perhaps by neutrophils.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486045     DOI: 10.1007/BF00199364

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  29 in total

1.  Polymorphonuclear leukocytes in antibody-dependent cellular cytotoxicity.

Authors:  R P Gale; J Zighelboim
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

2.  Relationship between size and perfusion rate of transplanted tumors.

Authors:  S CATALAND; C COHEN; L A SAPIRSTEIN
Journal:  J Natl Cancer Inst       Date:  1962-08       Impact factor: 13.506

3.  Regional blood flow by fractional distribution of indicators.

Authors:  L A SAPIRSTEIN
Journal:  Am J Physiol       Date:  1958-04

4.  Tumor necrosis factor.

Authors:  L J Old
Journal:  Clin Bull       Date:  1976

5.  Vascular reactions of normal and malignant tissues in vivo. IV. The effect of peripheral hypotension on transplanted tumors.

Authors:  G H ALGIRE; F Y LEGALLAIS
Journal:  J Natl Cancer Inst       Date:  1951-10       Impact factor: 13.506

6.  The therapeutic significance of concomitant antitumor immunity. I. LY-1-2+ T cells from mice with a progressive tumor can cause regression of an established tumor in gamma-irradiated recipients.

Authors:  R J North
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

Review 7.  The role of the macrophage in cardiac allograft rejection in the rat.

Authors:  G G MacPherson; S E Christmas
Journal:  Immunol Rev       Date:  1984       Impact factor: 12.988

8.  Antitumour activity of endotoxin, concanavalin A and poly I: C and their ability to elicit tumour necrosis factor, cytostatic factors, and interferon in vivo.

Authors:  N Bloksma; C F Kuper; F M Hofhuis; B Benaissa-Trouw; J M Willers
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

9.  The mediator of cellular immunity. 3. Lymphocyte traffic from the blood into the inflamed peritoneal cavity.

Authors:  F T Koster; D D McGregor
Journal:  J Exp Med       Date:  1971-04-01       Impact factor: 14.307

10.  Local opsonization by secreted macrophage complement components. Role of receptors for complement in uptake of zymosan.

Authors:  R A Ezekowitz; R B Sim; M Hill; S Gordon
Journal:  J Exp Med       Date:  1984-01-01       Impact factor: 14.307

View more
  6 in total

1.  Toxicity of tumor necrosis factor is synergistic with gamma-interferon and can be reduced with cyclooxygenase inhibitors.

Authors:  J E Talmadge; O Bowersox; H Tribble; S H Lee; H M Shepard; D Liggitt
Journal:  Am J Pathol       Date:  1987-09       Impact factor: 4.307

Review 2.  Vascular attack as a therapeutic strategy for cancer.

Authors:  J Denekamp
Journal:  Cancer Metastasis Rev       Date:  1990-11       Impact factor: 9.264

3.  Hypoxic tumor cell death and modulation of endothelial adhesion molecules in the regression of granulocyte colony-stimulating factor-transduced tumors.

Authors:  M P Colombo; L Lombardi; C Melani; M Parenza; C Baroni; L Ruco; A Stoppacciaro
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

4.  Influence of recombinant tumour necrosis factor alpha on blood flow and antibody localisation in human tumour xenografts in nude mice.

Authors:  M V Pimm; S J Gribben; T M Morris
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

5.  Synergistic effects of TNF-alpha and melphalan in an isolated limb perfusion model of rat sarcoma: a histopathological, immunohistochemical and electron microscopical study.

Authors:  P T Nooijen; E R Manusama; A M Eggermont; L Schalkwijk; J Stavast; R L Marquet; R M de Waal; D J Ruiter
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

6.  Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma.

Authors:  A Stoppacciaro; C Melani; M Parenza; A Mastracchio; C Bassi; C Baroni; G Parmiani; M P Colombo
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.